Author

Elena Sancho

Institute for Research in BiomedicineORCID 0000-0002-8182-513XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Ana Raquel HenriquesiD· 1 shared Antoni RiéraiD· 1 shared Carolina SáncheziD· 1 shared Daniel Byrom· 1 shared Daniele V. F. TaurielloiD· 1 shared Eduard BatlleiD· 1 shared Irene RuanoiD· 1 shared Israel RamosiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Ana Raquel HenriquesORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyACS Pharmacology & Translational SciencePeer-reviewedOct 1, 2024

HYL001, a new potent TGFβ signaling inhibitor that is efficacious against microsatellite stable CRC metastasis in combination with immune checkpoint therapy in mice

Daniele V. F. Tauriello, Elena Sancho, Daniel Byrom…·Antoni Riéra

This paper describes the development of HYL001, a TGFβ inhibitor that effectively combats microsatellite stable CRC metastasis in mice when combined with immune checkpoint therapy.

6 citations

mouseexperimental assay

𝕏 PostBluesky